When the 39 pharmaceutical companies'€™ case against the South African government started on 5 March, it ignited worldwide protests against drug profiteering at the expense of the world'€™s poor.But during the past five weeks that the court has been in recess, the international pharmaceutical industry mounted a major public relations offensive '€“ with price reductions for AIDS drugs as its centrepiece -- that seems to be paying off.